Results 271 to 280 of about 7,177,989 (337)

High Level of Component C1q Binding Protein (C1QBP) is Associated With Poor Prognosis and Dysfunction of Mast Cells in Lung Adenocarcinoma

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Component C1q binding protein (C1QBP) is known as an important regulator of mitochondrial plasticity and is involved in antitumor immune response in cancers. Nevertheless, its role in lung adenocarcinoma (LUAD) still remains largely unknown.
Wei Li   +9 more
wiley   +1 more source

c‐MET Inhibition Is Accompanied by PD‐L1 Upregulation and Immunosuppression‐Related Tumor Microenvironment Changes in Esophageal Squamous Cell Carcinoma, With Enhanced Antitumor Activity in Combination With Anti‐PD‐1 Therapy

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background c‐MET is implicated in ESCC progression, but whether c‐MET inhibition reshapes immune checkpoint expression and the tumor immune microenvironment remains unclear. Methods ESCC cell lines were treated with Tepotinib, and c‐MET and PD‐L1 expression were examined by Western blotting and immunofluorescence.
Chuan Song   +7 more
wiley   +1 more source

HK2/VDAC1 Axis Regulates Malignant Progression of Esophageal Squamous Cell Carcinoma. [PDF]

open access: yesCancer Med
Dai C   +12 more
europepmc   +1 more source

Divergent Roles of PIK3C3 in KRAS‐Wild‐Type and KRAS‐Mutant Advanced Colorectal Cancer: Implications for 5‐Fluorouracil Sensitivity and Prognosis

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
PIK3C3 plays divergent roles in KRAS‐WT and KRAS‐mutant CRCs, viz. targeting PIK3C3 suppresses KRAS/ERK pathway in KRAS‐WT CRC, while enhancing 5‐FU sensitivity in KRAS‐mutant CRC. ABSTRACT Introduction Phosphatidylinositol 3‐kinase catalytic subunit type 3 (PIK3C3) is central to autophagy, which supports cancer adaptation to environmental stresses and
Chien‐An Chu   +15 more
wiley   +1 more source

Discordant Primary Tumor and Nodal Response After Neoadjuvant Chemoimmunotherapy Identifies an Adverse Postoperative Subgroup in Esophageal Squamous Cell Carcinoma

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Primary‐tumor major pathological response (MPR) and postoperative nodal status are both used to assess response after neoadjuvant therapy for esophageal squamous cell carcinoma (ESCC), but discordant response after neoadjuvant chemoimmunotherapy is poorly characterized.
Yuxian Qian   +10 more
wiley   +1 more source

HtrA3 Promotes Malignant Progression of Colorectal Cancer and Is Associated With PI3K‐AKT‐FOXO1 Signaling

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT High‐temperature requirement protease A3 (HtrA3) has been implicated in the progression of various carcinomas through tissue‐specific mechanisms; however, its precise role in colorectal cancer (CRC) remains unclear. We initially identified the upregulation of HtrA3 in CRC tissues through Isobaric Tags for Relative and Absolute Quantitation ...
Jing Zheng   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy